Escient Pharmaceuticals Announces Presentation of Data Demonstrating Efficacy of EP262 in a Mouse Model of Atopic Dermatitis at ...
Data shows that EP262 attenuates skin inflammation in a human MRGPRX2 transgenic mouse model that replicates key pathophysiological features of human atopic dermatitis Results support the initiation of a clinical proof-of-concept study in atopic dermatitis …